版本:
中国

BRIEF-Imprimis Pharmaceuticals enters into agreements with two accredited investors

March 22 Imprimis Pharmaceuticals Inc

* Has entered into agreements with two accredited investors

* Agreements for a registered direct placement of 1.3 million shares of common stock at a price of $2.40 per share

* National Securities Corporation, a unit of National Holdings acted as exclusive placement agent for offering Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐